The Deauville 5-point scoring system is an internationally accepted and utilized five-point scoring system for the fluorodeoxyglucose (FDG) avidity of a Hodgkin lymphoma or Non-Hodgkin lymphoma tumor mass as seen on FDG positron emission tomography:[1]

  • Score 1: No uptake above the background
  • Score 2: Uptake ≤ mediastinum
  • Score 3: Uptake > mediastinum but ≤ liver
  • Score 4: Uptake moderately increased compared to the liver at any site
  • Score 5: Uptake markedly increased compared to the liver at any site
  • Score X: New areas of uptake unlikely to be related to lymphoma


Scores of 1 and 2 are considered to be negative and 4 and 5 are considered to be positive. "Score 3 should be interpreted according to the clinical context but in many Hodgkin Lymphoma patients indicates a good prognosis with standard treatment." [2]

History

Deauville score was developed at Guy's and Saint Thomas Hospital in London after an international meeting at Deauville, France in 2009.

References

  1. ↑ Barrington et al., Eur J Nucl Med Mol Imaging (2010) 37:1824–1833
  2. ↑ Follows et al, British Journal of Haematology, 2014, 166, 34–49.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.